|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2003-11-18
|
|
pubmed:abstractText |
The safety of delaying highly active antiretroviral therapy (HAART) in HIV-infected patients is uncertain when the CD4+ cell count declines below 0.350 x 10(9) cells/L.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1539-3704
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
18
|
|
pubmed:volume |
139
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
810-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14623618-Adult,
pubmed-meshheading:14623618-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:14623618-CD4 Lymphocyte Count,
pubmed-meshheading:14623618-Canada,
pubmed-meshheading:14623618-Cause of Death,
pubmed-meshheading:14623618-Female,
pubmed-meshheading:14623618-Follow-Up Studies,
pubmed-meshheading:14623618-HIV Infections,
pubmed-meshheading:14623618-Humans,
pubmed-meshheading:14623618-Life Tables,
pubmed-meshheading:14623618-Male,
pubmed-meshheading:14623618-Patient Compliance,
pubmed-meshheading:14623618-Prospective Studies,
pubmed-meshheading:14623618-Regression Analysis,
pubmed-meshheading:14623618-Time Factors
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.
|
|
pubmed:affiliation |
St. Paul's Hospital and University of British Columbia, Vancouver, British Columbia, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
